PECK KRISTIN C 4

What Happened

• Kristin C. Peck, CEO of Zoetis Inc., exercised 20,000 stock options on Feb 17, 2026 (exercise price $41.83 per share; total $836,600) and sold a total of 20,000 shares the same day in open-market transactions for aggregate proceeds of approximately $2,540,964.
• The sales were in two blocks: 9,200 shares at a weighted average price of $126.46 (proceeds $1,163,433) and 10,800 shares at a weighted average price of $127.55 (proceeds $1,377,531). The filing also lists a 20,000-share derivative disposition reported at $0.00 (reported as an exercise/conversion entry).

Key Details

• Transaction date: Feb 17, 2026.
• Options exercised: 20,000 shares at $41.83 each (total cost $836,600).
• Shares sold: 9,200 @ weighted avg $126.46 (range $126.01–$126.98) and 10,800 @ weighted avg $127.55 (range $127.01–$127.56); total proceeds ≈ $2.54M.
• Notable footnote: Sales were effected under a Rule 10b5-1 trading plan adopted Sep 12, 2025 that allowed sale of up to 20,000 shares upon exercise of options expiring Feb 18, 2026.
• Vesting/option notes: Footnotes show various option grants and vesting schedules; some referenced options vest over three years and expire ten years after grant.
• Shares owned after transaction: Not specified in the provided excerpt — see the full Form 4 for updated ownership.
• Filing timeliness: Form filed Feb 17, 2026 (no late filing indicated in the provided data).

Context

• This was an exercise of vested options followed by same-day open-market sales under a prearranged 10b5-1 plan. Such transactions are commonly used to exercise expiring options and to sell acquired shares according to a preset plan; they are routine and do not by themselves indicate CEO sentiment about the company.
• For full details (exact post-transaction holdings, option grant dates/prices, and any tax-withholding or share-surrender mechanics), retail investors should review the complete Form 4 (accession 0001628280-26-008594).